ePrescribing Market – By Product (Solutions {Integrated, Standalone}, Services), Delivery Mode (Web/Cloud-based, On-premises), Substances (Controlled, Non-controlled), Usage (Handheld, Computer-based), Specialties, End-use, Global Forecast (2024 – 2032)

ePrescribing Market – By Product (Solutions {Integrated, Standalone}, Services), Delivery Mode (Web/Cloud-based, On-premises), Substances (Controlled, Non-controlled), Usage (Handheld, Computer-based), Specialties, End-use, Global Forecast (2024 – 2032)

ePrescribing Market Size

ePrescribing Market size was valued at USD 2.8 billion in 2023 and is predicted to showcase growth of 23.9% from 2024 to 2032. Growing adoption of electronic health records (EHR) significantly contributes to the market by facilitating seamless integration, enhancing patient safety, improving care coordination and supporting regulatory compliance.

To get key market trends

  Download Free Sample

As healthcare organizations continue to prioritize digital transformation and interoperability initiatives, the synergistic relationship between EHR and ePrescribing technologies is expected to drive the innovation further, thereby augmenting the healthcare IT landscape.

What are the growth opportunities in this market?

 Download Free Sample

ePrescribing, also known as electronic prescribing, is a technology-driven process that enables healthcare providers to generate, transmit, and manage prescriptions for medications electronically, instead of using traditional paper-based methods. ePrescribing systems streamline the prescription process, improve medication management, and enhance patient safety by leveraging digital technologies and electronic communication.

ePrescribing Market Trends

• Minimization of prescription errors is a significant factor contributing to the growth and adoption of ePrescribing solutions in the healthcare market. This enables for improved patient safety, enhanced quality of care, and increased efficiency in medication management. Therefore, as healthcare providers and organizations prioritize patient safety and regulatory compliance, the adoption of ePrescribing solutions is expected to continue to grow, thereby driving market expansion and innovation in the market.

However, the concerns pertaining to patient data security of patient data due to its utilization of cloud-based data storage could potentially decrease the acceptance of e-prescribing systems, thereby impeding market expansion.

ePrescribing Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

The market based on product is segmented into solutions and services. The solution segment accounted for majority of market share of 61.2% in 2023.

• This substantial market share is due to increased penetration of different software that help in managing the workflow especially in hospital and pharmacy setting. Also, it assists in streamlining patients' treatment coordination by consolidating their complete drug history into a unified portal, which demands fewer resources compared to integrated systems.

Learn more about the key segments shaping this market

 Download Free Sample

The ePrescribing market based on delivery mode is classified into web/cloud-based and on-premises. The web/cloud-based segment dominated the market and is expected to reach USD 10.8 billion by 2032.

• The reduced cost in comparison to on-premises solutions is contributing to the segmental growth. Community hospitals, clinics, solo practitioners, and physician offices that cannot afford the expensive upfront expenditures of on-premises systems find a cloud platform to be a compelling alternative. Therefore, availability of cloud-based software from Athenahealth, Allscripts, and eClinicalWorks will foster the segmental growth.

Based on substances, the ePrescribing market is classified into controlled substances and non-controlled substances. The controlled substances dominated the market and is expected to exhibit 24.3% during the analysis period.

• The adoption of electronic prescribing of controlled substances (EPCS) is driven by several factors. Regulatory mandates from agencies such as the DEA in the U.S. require healthcare providers to use electronic prescribing systems for controlled substances. This mandate aims to enhance prescription security, reduce fraud, and improve accuracy. Also, EPCS offers improved security features such as encryption and identity verification, which help prevent prescription fraud and abuse.
• Moreover, the integration of EPCS with electronic health records (EHRs) facilitates seamless data exchange and communication between healthcare providers and pharmacies.

Based on usage, the ePrescribing market is classified into handheld and computer-based devices. The handheld segment accounted for USD 1.6 billion in 2023.

• The proliferation of smartphones and tablets has led to the development of mobile applications specifically designed for ePrescribing. These applications enable healthcare providers to access ePrescribing functionalities directly from their handheld devices, allowing for convenient and efficient prescribing workflows.
• Also, point-of-care prescribing via handheld devices supports patient-centered care and contributes to improved medication adherence and outcomes. Thus, aforementioned factors are anticipated to accelerate the segmental growth.

The ePrescribing market based on specialties is segmented into oncology, sports medicine, neurology, cardiology, and other specialties. The sports medicine segment accounted for market share of 30.4% in 2023.

• Sports medicine practitioners often require specific medication regimens tailored to the unique needs of athletes and sports-related injuries. Hence, the integration between ePrescribing systems and athlete health monitoring platforms is becoming more prevalent in sports medicine practice. By integrating data from wearable devices, fitness trackers, and athlete health monitoring systems, ePrescribing platforms can provide sports medicine practitioners with real-time insights into athletes' health status, performance metrics, and injury risk factors. Thus, usage of ePrescribing in sports sector will supplement the market growth.

Based on end-use, the ePrescribing market is classified into hospital, office-based physicians, pharmacy, and other end-users. The hospitals segment dominated the market and is expected to exhibit 24% CAGR between 2024 – 2032.

• Hospitals are the early adopters of digital solutions, including e-prescribing or electronic health record (EHR) solutions, due to their recognition of the potential benefits. Also, the hospitals typically manage large volumes of patient data and complex workflows, making digital solutions essential for streamlining processes and improving efficiency.
• E-prescribing systems allow healthcare providers to electronically send prescriptions directly to pharmacies, reducing the risk of errors associated with handwritten prescriptions and expediting medication orders. Therefore, widespread adoption of ePrescribing solution will enable to improve operational efficiency, enhance patient care, and meet regulatory requirements in an increasingly digital healthcare landscape, thereby boosting the segmental growth.

Looking for region specific data?

 Download Free Sample

North America ePrescribing market accounted for USD 1.2 billion market revenue in 2023 and is anticipated to grow at CAGR of 23.8% between 2024 – 2032 period.

• The North America market is characterized by the presence of several key players offering comprehensive ePrescribing solutions tailored to the needs of healthcare providers and pharmacies. These solutions encompass features such as electronic medication reconciliation, formulary checking, drug interaction alerts, and electronic prior authorization capabilities.
• Therefore, technological advancements in healthcare IT infrastructure, including electronic health record (EHR) systems and interoperability standards, have facilitated the integration of e-prescribing functionalities into existing healthcare workflows, thereby propelling the regional market growth.

ePrescribing Market Share

The ePrescribing industry is characterized by the presence of several key players offering innovative solutions. The business initiatives such as partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

ePrescribing Market Companies

Prominent players operating in the ePrescribing industry include

• Allscripts Healthcare, LLC
• Athenahealth
• Change Healthcare
• DrFirst
• Epic Systems Corporation
• McKesson Corporation
• Networking Technology, Inc
• NXGN Management, LLC
• Practice Fusion, Inc.
• Surescripts

ePrescribing Industry News

• In March 2022, FDB (First Databank, Inc.) has introduced FDB Vela, a cloud-native e-prescribing network designed to facilitate the seamless exchange of crucial medication prescription information, benefits verification, and clinical decision support among prescribers, payers, pharmacies, and other stakeholders. This innovative network aims to enhance the efficiency and accuracy of the prescribing process, ultimately improving patient care and outcomes.
• In October 2021, Allscripts Healthcare Solutions' Veradigm partnered with CareMetx, LLC to optimize end-to-end specialty medication access and services, streamlining patient care. This collaboration enhanced the patient experience by providing comprehensive solutions that facilitate access to specialty medications.

The ePrescribing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments

Click here to Buy Section of this Report

Market, By Product

• Solutions
  • Integrated solutions
  • Standalone solutions
• Services
  • Support
  • Implementation
  • Training
  • Network

Market, By Delivery Mode

• Web/cloud-based
• On-premises

Market, By Substances

• Controlled substances
• Non-controlled substances

Market, By Usage

• Handheld
• Computer-based devices

Market, By Specialties

• Oncology
• Sports medicine
• Neurology
• Cardiology
• Other specialties

Market, By End-use

• Hospital
• Office-based physicians
• Pharmacy
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East and Africa